The biggest payer and provider trends from Q2

compounding

Hims Hers branded GLP-1
Health Tech

Higher expenses in Q2 drive $86M loss for Hims & Hers

The company reported strong revenue growth in the second quarter, bringing in $753 million, up 38% compared to revenue of $545 million a year ago.
Heather Landi Aug 11, 2026 4:45pm
Hims Hers branded GLP-1

Hims & Hers swings to a loss in Q1 amid shift in GLP-1 strategy

May 12, 2026 4:00pm
Red computer key with a warning symbol on it
Favicon Fierce Pharma

FDA unleashes warning letters to firms selling compounded GLP-1s

Mar 4, 2026 8:30am
Hims Hers Super Bowl commercial

Hims & Hers downplays business impact of compounded GLP-1s

Feb 25, 2026 1:30pm
Weight loss pills Obesity treatment

OpenLoop, Triad Rx sued over 'snake oil' compounded GLP-1

Feb 13, 2026 3:35pm
arrow back backwards u-turn turn around reverse
Favicon Fierce Pharma

Hims quits on obesity pill after legal, regulatory heat

Feb 9, 2026 10:24am